Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price traded up 1.8% during mid-day trading on Wednesday . The company traded as high as €59.95 ($68.13) and last traded at €57.60 ($65.45). 278,528 shares changed hands during mid-day trading, an increase of 195% from the average session volume of 94,405 shares. The stock had previously closed at €56.60 ($64.32).
Carl Zeiss Meditec Price Performance
The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41. The business’s 50-day simple moving average is €58.61 and its 200-day simple moving average is €56.94. The stock has a market cap of $5.37 billion, a PE ratio of 30.78, a PEG ratio of 2.83 and a beta of 0.98.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
